Search the Newsreel

Total liabilities of Citizens Financial Group, Inc. – HAM:1C5

This article provides financial information for Citizens Financial Group, Inc. (HAM:1C5) on TradingView, focusing specifically on its total liabilities. It mentions the company's presence on the Hamburg Stock Exchange and indicates that market data is provided by ICE Data Services and FactSet. The core …

1C5 Stock Price and Chart — HAM:1C5

This page provides a detailed overview of Citizens Financial Group, Inc. (1C5) stock on the Hamburg Stock Exchange, including its key financial statistics, upcoming earnings reports, and analyst ratings. It also features various trading ideas and analyses from different users, offering diverse perspectives on …

Loan losses (actual) of Citizens Financial Group, Inc. – HAM:1C5

This page provides financial data on the actual loan losses of Citizens Financial Group, Inc. (HAM:1C5), listed on the Hamburg Stock Exchange. The content is primarily a data page, indicating that the market was closed with no trades at the time of viewing.

Citizens Financial Services Inc (CZFS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Citizens Financial Services Inc (CZFS) has an earnings forecast score of 8.00, ranking 53rd in the Banking Services industry. Analysts project a price target of $64.36 with a "Buy" rating. The company's expected revenue for the next quarter is $25.80 million, with an anticipated …

Brean Capital Downgrades Citizens Community Bancorp (NASDAQ:CZWI) to Neutral

First Citizens (NASDAQ: FCNCA) net income hits $1,206M YTD 2026

Zentalis Pharmaceuticals, Inc. 2Q 2026: Net loss $(42.3M), EPS $(0.59) — 10-Q Summary

Zentalis Pharmaceuticals, Inc. reported a net loss of $(42.3M) and a diluted loss per share of $(0.59) for the second quarter of 2026, remaining a pre-revenue company. The company is advancing its clinical development for azenosertib, including a Phase 3 study and biomarker strategy, …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This follows Azenta's Q2 2026 financial results, which missed consensus estimates for EPS and revenue, reported a $149 million goodwill impairment, and led to a reduced …

Surrozen, Inc. 2Q 2026: Revenue $5M, Net income $50.18M, EPS $(0.41) — 10-Q Summary

Surrozen, Inc. reported its second-quarter 2026 results, showing a significant increase in revenue to $5M, up 408% year-over-year, and net income of $50.18M. This growth was primarily driven by collaboration milestone recognition and noncash fair value gains. The company also highlighted pipeline progress with …

Zenith Exports Ltd. (ZENITHEXPO) Share Price Rises 9.48% as Micro Cap Stock Enters Top Gainers Today

Citizens Financial pauses just below its high while a 54-week trend streak stays intact

CFG finished the week at $71.65, only 3.5% beneath its 52-week high, with regional-bank breadth supportive but volume still no better than baseline.

Citizens & Northern Corp (CZNC) director adds to holdings under 10b5-1 plan

Citizens & Northern Corp director Katherine W. Shattuck purchased 8 shares of common stock at $25.215 per share on August 7, 2026, through an open-market transaction under a pre-existing Rule 10b5-1 trading plan. Following this acquisition, her direct holdings in CZNC increased to 10,601 …

Takeover Activity Puts Zenith Minerals (ASX:ZNC) at the Centre of a Corporate Contest

Renaissance Technologies LLC Lowers Position in Zentalis Pharmaceuticals, Inc. $ZNTL

Citizens & Northern (NASDAQ:CZNC) Issues Earnings Results

Jiangsu Zenergy flags profit jump on battery shipment surge and cost efficiencies

Morgan Stanley Adjusts PT on Zentalis Pharmaceuticals to $5 From $4, Maintains Equalweight Rating

Morgan Stanley has increased its price target for Zentalis Pharmaceuticals (ZNTL) from $4 to $5, while reiterating an "Equalweight" rating on the stock. This adjustment reflects a modest upgrade in the firm's outlook for the clinical-stage biopharmaceutical company, which specializes in developing small molecule …

How the FTSE became a ‘departure lounge’ for British companies

On holiday in Devon this summer, Charles Hall felt a familiar sinking feeling. The most senior analyst at City stockbroker Peel Hunt had just read that AstraZeneca held talks with US pharmaceutical giant Bristol Myers Squibb about a potential merger. It reignited concerns that …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN

Pomerantz LLP is investigating potential claims on behalf of investors of AstraZeneca PLC (NYSE: AZN) following a significant drop in its stock price. This investigation comes after AstraZeneca disclosed that its late-stage Phase-3 CARDIO-TTransform trial for Wainua, an amyloid cardiomyopathy treatment, failed to meet …

Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed

Azenta, Inc. recently reported third-quarter 2026 results showing revenue of US$161.18 million versus US$143.86 million a year earlier, swung to a quarterly net income of US$2.46 million from a net loss, modestly raised full-year revenue guidance to US$613–US$618 million, and completed a US$50 million …

Citizens Financial Services (CZFS) 10K Form and Latest SEC Filings 2026

This article provides an overview of Citizens Financial Services (CZFS) SEC filings, highlighting that the company has submitted over 762 documents since 2017. It details recent filings including a Form 10-Q on August 6, 2026, a Form 8-K on July 30, 2026, and various …

ZenaTech closes 27th Drone as a Service acquisition, expands into Idaho

ZenaTech has completed its 27th Drone as a Service acquisition, extending its operations into Idaho. This strategic move aims to strengthen its drone-based surveying and civil engineering services for both government and construction clients. The information was originally published by Zenatech Inc. via EDGAR …

Zentek Ltd (ZTEK) Stock News Today

This article provides the latest stock news for Zentek Ltd (ZTEK) on TradingKey. It shows the current stock price, market capitalization, and a general overview of the company's financial information and news. The content indicates that more news will be coming soon for Zentek …

Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA

Arrowstreet Capital Limited Partnership has acquired a new position in Azenta, Inc. (NASDAQ:AZTA), purchasing 71,410 shares valued at approximately $1.51 million, representing about 0.15% of the company. This comes as Azenta reported strong quarterly earnings, exceeding analyst estimates for both EPS and revenue, though …

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Earnings Results

AstraZeneca Stock Leads 3 Cash Flow Picks Worth Watching In Europe

ZenaTech, Inc. acquired Benchmark Partners LLC.

ZenaTech, Inc. (NasdaqCM:ZENA) announced the acquisition of Benchmark Partners LLC, which was completed on August 6, 2026. This acquisition is part of ZenaTech's ongoing expansion, following several other recent acquisitions and inclusions in various Russell indexes. ZenaTech specializes in AI drones, Drone as a …

Zenas BioPharma, Inc. (ZBIO) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before June 16, 2025

Levi & Korsinsky is urging investors who suffered losses in Zenas BioPharma, Inc. (ZBIO) to contact them before June 16, 2025, regarding a potential lawsuit. The lawsuit alleges that Zenas BioPharma made false statements about its ability to fund operations following its September 2024 …

Citizens, Inc. Reports Second Quarter 2026 Financial Results

Citizens, Inc. (NYSE: CIA) reported its financial results for the second quarter ended June 30, 2026, highlighting its fifteenth consecutive quarter of year-over-year direct first-year premium growth and an increase in book value per Class A share for the fourteenth consecutive quarter. The company …

Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary

Azenta, Inc. reported strong third-quarter 2026 results, with revenue increasing 12% year-over-year to $161.18 million and diluted EPS reaching $0.05, a significant improvement from a loss in the prior year. The company returned to a net income of $2.46 million, driven by growth in …

ZenaTech (Nasdaq: ZENA) grows DaaS footprint and boosts Boardwalktech stake

ZenaTech (Nasdaq: ZENA) is expanding its "Drone as a Service" (DaaS) operations through strategic acquisitions in Ohio and Idaho, extending its U.S. presence to 13 states. The company is also advancing its ZenaDrone technology, including flight testing for the Interceptor P-1 counter-drone system and …

Citizens Financial Group Inc. stock outperforms competitors despite losses on the day

Citizens Financial Group Inc. (CFG) stock declined by 1.59% on Thursday, closing at $72.43. This occurred during a general market downturn where the S&P 500 Index fell by 0.18% and the Dow Jones Industrial Average dropped by 0.85%. Despite the loss, the article title …

Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update

Surrozen, Inc. (Nasdaq: SRZN) announced its financial results for the second quarter ended June 30, 2026, and provided a business update. The company plans to submit an IND application for SZN-8141 for diabetic macular edema (DME) by the end of Q3 2026 and initiate …

Roadzen (NASDAQ:RDZN) Stock Price Up 6.1% - Should You Buy?

Roadzen (NASDAQ:RDZN) shares increased by 6.1% on Monday, trading at $1.22, though volume was below average. The stock remains below its 50-day and 200-day moving averages, and analysts have a cautious "Reduce" consensus rating based on one Hold and one Sell. The company missed …

Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates

Zentalis Pharmaceuticals announced its Q2 2026 financial results, reporting $174.6 million in cash, providing runway into late 2027. The company highlighted progress in its late-stage WEE1 inhibitor, azenosertib, for ovarian cancer, with the DENALI trial's accelerated approval strategy intact following FDA discussions. Topline data …

CFG vs. CBC: Which Stock Is the Better Value Option?

Investors looking for stocks in the Banks - Northeast sector might want to consider either Citizens Financial Group (CFG) or Central Bancompany (CBC). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take …